| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
The Week in Review provides an overview of the past week’s top health care content, including industry news and trends, Mayo Clinic and Mayo Clinic Laboratories news, and upcoming events.
Long COVID affects more older adults; shots don’t prevent it
A study of U.S. veterans published this week showed that one-third of those who had breakthrough COVID-19 infections also showed signs of long COVID. A separate study showed that in adults aged 65 and older, one in four had potential long COVID issues. Via AP
UnitedHealth leans into telehealth to reduce costs, meet patient needs
UnitedHealth Group Inc., the healthcare and health insurance giant, has built telehealth into strategies the company’s chief executive says are needed to reduce wasteful spending and meet the chronic need for more behavioral healthcare nationally. Via Wall Street Journal
US has a new dominant COVID-19 strain
The omicron subvariant BA.2.12.1 is now accounting for more than 50 percent of all U.S. COVID-19 cases. BA.2.12.1 is thought to be 25 percent more transmissible than its predecessor BA.2. Via Becker's
Mayo Clinic, CDC address concerns over monkeypox in the US
You've probably heard about it by now, but what is it and is it a threat that you need to worry about? "It's in the same family as smallpox but it should not be confused with it in terms of level of alarm. With smallpox, 10-30% of people can die," said Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group, in a recent podcast. Via Bring Me the News
Mayo Clinic, Janssen-backed venture gets FDA OK for pulmonary hypertension AI algorithm
A Mayo Clinic and Janssen-backed venture has received FDA breakthrough designation for an algorithm designed to enable early detection of pulmonary hypertension. Anumana Inc. received the breakthrough device designation for its AI-enhanced, ECG-based algorithm screening tool that provides early diagnosis of patients with pulmonary hypertension, according to a May 24 press release. Via Becker's
How we can transform healthcare by moving from pipeline to platform
"To spur transformation, we must first change our thinking. We must move from traditional, linear pipeline-service-model thinking to a platform approach, which brings together longitudinal medical data, producers and consumers to co-create a new healthcare paradigm that fundamentally changes how we provide healthcare and advance cures." Via World Economic Forum
